−£208k
vs Mar 2025Active14844370Private limited companyNewmarket
BENSEN PHARMA LIMITED
Significant control: Andrew Richard Boyce (significant control)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Coming soon · product and service lists
What does Bensen Pharma Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
BENSEN PHARMA LIMITED is an active private limited company (company number 14844370) incorporated on 3 May 2023, registered in Newmarket. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 March 2026, showing net assets of −£208k and cash of £390, with 0 employees on average. Net assets fell 16% on the prior period (−£179k). Across the last 3 periods on record the net-asset trend is falling.
Peer position · net assets
By net assets it sits in the bottom quarter of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
02
Ownership and control
- Mr Andrew Richard Boyce
- has significant influence or control
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 3 May 20233 yrs ago
- Next accounts due
- 31 December 2027in 434 days
- Confirmation statement due
- 17 May 2027in 206 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£390
+41%vs Mar 2025Not reported
0
vs Mar 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 March 2026 | −£208k | £390 | — | £316k | — | — | 0 |
| 31 March 2025 | −£179k | £276 | — | £288k | — | — | 0 |
| 31 March 2024 | −£108k | £2,590 | — | £196k | — | — | 0 |
Current ratio0.09Current assets ÷ creditors within one year
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets below zeroNet assets £-207,623 at 31 March 2026
- Current assets below creditors within one yearCurrent ratio 0.09
- Three or more accounting periods on record3 periods on record
- Incorporated two to five years agoIncorporated 3 May 2023
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 434 days
- Confirmation statement duein 206 days
- Accounts period endNet liabilities £208k · small accounts
- Accounts period endNet liabilities £179k · small accounts
- Accounts period endNet liabilities £108k · small accounts
- Incorporated
08
Similar companies in Cambridge
- BENSEN HOLDINGS LIMITEDNewmarket · inc. May 2023
- CELLESTIAL HEALTH LTDCambridge · inc. Apr 2023
- TRUTINA THERAPEUTICS LTDCambridge · inc. Apr 2023
- RNAVATE LIMITEDCambridge · inc. Mar 2023
- CYTEK BIOSCIENCES LTDEly · inc. Mar 2023
- CAMGENE THERAPEUTICS LIMITEDCambridge · inc. Jun 2023
All companies incorporated on 3 May 2023 · in May 2023.
09
Reminders for BENSEN PHARMA LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.